Arena Pharmaceuticals, Inc. (ARNA) Posts Q3 Loss of 8c/Share

November 7, 2013 4:11 PM EST Send to a Friend
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) reported Q3 EPS of ($0.08) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login